- $18.31bn
- $18.75bn
- $2.07bn
- 97
- 11
- 94
- 75
Annual cashflow statement for Insulet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 6.8 | 16.8 | 4.6 | 206 | 418 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 85.2 | 121 | 53.7 | 57.2 | 85.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -63.4 | -264 | -2.5 | -191 | -17 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | 84 | -68.1 | 119 | 146 | 430 |
Capital Expenditures | -167 | -123 | -157 | -109 | -134 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | 181 | 40 | -33.8 | -10.2 | -12.2 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 14 | -82.7 | -191 | -119 | -146 |
Financing Cash Flow Items | -32 | -32.2 | -16.8 | -13.5 | -7.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 606 | 40.7 | -40.3 | -13.6 | -28.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 708 | -116 | -117 | 14.5 | 249 |